Intrinsic Value of S&P & Nasdaq Contact Us

Prenetics Global Limited PRE NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • HK • USD

SharesGrow Score
61/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$36.00
+99.9%

Prenetics Global Limited (PRE) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

The consensus price target is $36.00, representing an upside of 99.9% from the current price $18.01.

Analysts estimate Earnings Per Share (EPS) of $-3.30 and revenue of $0.03B for the next fiscal year.

Earnings Per Share (EPS) track record: 2025: actual $-4.15 vs est $-2.52 (missed -64.9%). Analyst accuracy: 61%.

PRE Stock — 12-Month Price Forecast

$36.00
▲ +99.89% Upside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for Prenetics Global Limited, the price target is $36.00.
The average price target represents a +99.89% change from the last price of $18.01.

PRE Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Prenetics Global Limited in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — PRE

61%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024 Actual $0.00 vs Est –$3.30 ▲ 0.0% off
2025 Actual –$4.15 vs Est –$2.52 ▼ 39.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — PRE

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.031B vs Est $0.033B ▼ 6.5% off
2025 Actual $0.092B vs Est $0.090B ▲ 2.4% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message